Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member., inc. (CRM), ExactTarget Inc (ET): Pros and Cons of This Cloud Acquisition

Page 1 of 2, inc. (NYSE:CRM) announced its plans to acquire cloud-based digital marketing company ExactTarget Inc (NYSE:ET) last week. The deal has Salesforce paying a 53% premium for ExactTarget, which is clearly a big win for the takeover target’s shareholders. The market is unsure if the deal is so great for Salesforce., inc. (NYSE:CRM)

Let’s take a look at the pros and cons of Salesforce’s latest acquisition, and then come to a verdict.


  • Stay ahead of the competition. The ExactTarget Inc (NYSE:ET) purchase keeps in the pole position of cusomer relationship management, or CRM, services. Big names such as Oracle Corporation (NASDAQ:ORCL) are making moves into the cloud CRM space. Oracle bought up PeopleSoft and Siebel last decade, but most recently paid $871 million for ExactTarget competitor Eloqua.Interestingly, many Eloqua users also use Salesforce’s CRM software. But Oracle is working hard to better integrate Eloqua with its own CRM services, and convincing Eloqua subscribers to buy the rest of Oracles sales suite. The effect is double edged – decreased revenue at, inc. (NYSE:CRM), increased revenue at Oracle.Meanwhile, companies like Microsoft Corporation (NASDAQ:MSFT) and SAP AG (ADR) (NYSE:SAP) are expected to make moves to bolster their CRM services. Microsoft is pushing its Microsoft Dynamics service, which focuses on small businesses compared to SAP, Oracle, or Salesforce.Microsoft Dynamics is a $1.1 billion business that grew revenue 26% last year, but still lags well behind Salesforce, SAP, and Oracle. While SAP and Oracle are seeing relatively slow growth, Salesforce continues to grow rapidly – also 26% last year – particularly through acquisitions. Microsoft may consider purchasing Marketo, the long rumored takeover target, in an effort to leapfrog the competition and catch up to Salesforce.ExactTarget keeps ahead of the competition, as it was one of the first movers in the segment and considered the best platform in marketing software-as-a-service, or SaaS. It’s software was revamped recently to coordinate with many new big data technologies.
  • Strengthens its weakness. There are three pillars to’s business – sales, service, and marketing. The latter is certainly the company’s biggest weakness, as it’s a leader in the two former pillars.The company is working hard to improve its marketing CRM SaaS. It bought Radian6 and Buddy Media last year, which both offer services for social media marketing. ExactTarget Inc (NYSE:ET) is a step above both of those businesses. It adds robust email marketing services – something almost every company uses.
  • ExactTarget adds a lucrative business model to, inc. (NYSE:CRM). It sells subscriptions to access its software, and then charges per email sent too.It has a customer base of over 6,000 clients including big names such as The Coca-Cola Company (NYSE:KO), NIKE, Inc. (NYSE:NKE), Groupon Inc (NASDAQ:GRPN), and The Gap Inc. (NYSE:GPS). Most of ExactTarget’s clients are business-to-consumer companies, which means a lot of new clients for Salesforce, which usually works with business-to-business companies.
  • The two companies are synergistic. With a load of new clients coming into the ecosystem, the company will have a tremendous opportunity to cross-sell complimentary CRM services. The two companies worked closely together before, so many companies will already be familiar with Salesforce’s products, making sales easier.
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!